Daktari Biotechnology will deploy optimized BacMam mammalian transduction and expression technology that combines new vector technology and human cell lines that significantly improve protein expression levels and scalable for commercial protein production platform in stirred-tank bioreactors. When combined with modern purification technology, the Daktari Biotech's therapeutic protein produced using this technology will be expressed with proper post-translational modification almost identical to those naturally produced by human bodies.